LitAlert ~~ GeneLit.com

    • Association of a novel BRCA2 mutation with prostate cancer risk further supports germline genetic testing.
    • Foley GR, Marthick JR, Ostrander EA, Stanford JL, Dickinson JL, FitzGerald L.
    • Eur J Cancer. 2023 Feb 1;180:155-157. doi: 10.1016/j.ejca.2022.11.034. Epub ahead of print.
    • Case report
    • PLA2G7/PAF-AH as Potential Negative Regulator of the Wnt Signaling Pathway Mediates Protective Effects in BRCA1 Mutant Breast Cancer.
    • Liao Y, Badmann S, Kraus F, Topalov NE, Mayr D, Kolben T, Hester A, Beyer S, Mahner S, Jeschke U, Trillsch F, Czogalla B, Burges A.
    • Int J Mol Sci. 2023 Jan 3;24(1):882. doi: 10.3390/ijms24010882.
    • Treatment Complexities Continue to Mount in Gynecologic Cancers.
    • Lovely B.
    • OncLive. OncologyLive. 2023 Jan 3;23(24):35.
    • Exploration of Chemotherapy-Free Regimen After Multi-Line Chemotherapy-Induced Renal Impairment in Recurrent Ovarian Cancer: Case Report and Literature Review.
    • Zhang LP, Yang X, Zheng W, Feng KX, Li H.
    • Front Oncol. 2022 Dec 29;12:1031045. doi: 10.3389/fonc.2022.1031045.